PubMed:19451857 JSONTXT

{"project":"Inflammaging","denotations":[{"id":"T1","span":{"begin":0,"end":126},"obj":"Sentence"},{"id":"T2","span":{"begin":127,"end":288},"obj":"Sentence"},{"id":"T3","span":{"begin":289,"end":351},"obj":"Sentence"},{"id":"T4","span":{"begin":352,"end":473},"obj":"Sentence"},{"id":"T5","span":{"begin":474,"end":556},"obj":"Sentence"},{"id":"T1","span":{"begin":0,"end":126},"obj":"Sentence"},{"id":"T2","span":{"begin":127,"end":288},"obj":"Sentence"},{"id":"T3","span":{"begin":289,"end":351},"obj":"Sentence"},{"id":"T4","span":{"begin":352,"end":473},"obj":"Sentence"},{"id":"T5","span":{"begin":474,"end":556},"obj":"Sentence"}],"text":"Bacteremia caused by an Enterococcus faecalis isolate with high-level linezolid resistance in a teenager with Crohn's disease.\nLinezolid is an antibiotic used to treat highly resistant infections, including vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus. Enterococcus faecalis bacteremia occurs in pediatric patients. We present a teenager admitted for bacteremia caused by E faecalis with a distinctive pattern of resistance to linezolid. This organism has the highest MIC to linezolid reported in the literature to date."}

{"project":"disease_gene_microbe_small","denotations":[{"id":"T0","span":{"begin":110,"end":125},"obj":"DOID:8778"},{"id":"T1","span":{"begin":24,"end":45},"obj":"taxonomy:1351"}],"namespaces":[{"prefix":"DOID","uri":"http://disease-ontology.org/term/DOID:"},{"prefix":"taxonomy","uri":"https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info\u0026id="}],"text":"Bacteremia caused by an Enterococcus faecalis isolate with high-level linezolid resistance in a teenager with Crohn's disease.\nLinezolid is an antibiotic used to treat highly resistant infections, including vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus. Enterococcus faecalis bacteremia occurs in pediatric patients. We present a teenager admitted for bacteremia caused by E faecalis with a distinctive pattern of resistance to linezolid. This organism has the highest MIC to linezolid reported in the literature to date."}

{"project":"PubCasesHPO","denotations":[{"id":"TI1","span":{"begin":110,"end":125},"obj":"HP:0100280"}],"text":"Bacteremia caused by an Enterococcus faecalis isolate with high-level linezolid resistance in a teenager with Crohn's disease.\nLinezolid is an antibiotic used to treat highly resistant infections, including vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus. Enterococcus faecalis bacteremia occurs in pediatric patients. We present a teenager admitted for bacteremia caused by E faecalis with a distinctive pattern of resistance to linezolid. This organism has the highest MIC to linezolid reported in the literature to date."}